Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 344

1.

French Endocrine Society Guidance on endocrine side-effects of immunotherapy.

Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F.

Endocr Relat Cancer. 2018 Oct 1. pii: ERC-18-0320.R1. doi: 10.1530/ERC-18-0320. [Epub ahead of print]

PMID:
30400055
2.

Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma.

Job S, Draskovic I, Burnichon N, Buffet A, Cros J, Lépine C, Venisse A, Robidel E, Verkarre V, Meatchi T, Sibony M, Amar L, Bertherat J, de Reyniès A, Londoño-Vallejo A, Favier J, Castro-Vega LJ, Gimenez-Roqueplo AP.

Clin Cancer Res. 2018 Oct 9. pii: clincanres.0139.2018. doi: 10.1158/1078-0432.CCR-18-0139. [Epub ahead of print]

PMID:
30301828
3.

Genetics of adrenal tumors.

Bertherat J.

Presse Med. 2018 Jul - Aug;47(7-8 Pt 2):e107-e108. doi: 10.1016/j.lpm.2018.08.007. No abstract available.

PMID:
30172347
4.

Expert opinions on adrenal complications in immunotherapy.

Haissaguerre M, Hescot S, Bertherat J, Chabre O.

Ann Endocrinol (Paris). 2018 Oct;79(5):539-544. doi: 10.1016/j.ando.2018.07.002. Epub 2018 Jul 11.

PMID:
30149891
5.

Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions.

Castinetti F, Albarel F, Archambeaud F, Bertherat J, Bouillet B, Buffier P, Briet C, Cariou B, Caron P, Chabre O, Chanson P, Cortet C, Do Cao C, Drui D, Haissaguerre M, Hescot S, Illouz F, Kuhn E, Lahlou N, Merlen E, Raverot V, Smati S, Verges B, Borson-Chazot F.

Ann Endocrinol (Paris). 2018 Oct;79(5):591-595. doi: 10.1016/j.ando.2018.07.005. Epub 2018 Jul 11.

PMID:
30056975
6.

65 YEARS OF THE DOUBLE HELIX: It's all in the DNA: understanding and managing endocrine neoplasms.

Foulkes WD, Bertherat J, Eng C.

Endocr Relat Cancer. 2018 Aug;25(8):E5-E7. doi: 10.1530/ERC-18-0283. No abstract available.

PMID:
29980642
7.

Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.

Renaudin K, Smati S, Wargny M, Al Ghuzlan A, Aubert S, Leteurtre E, Patey M, Sibony M, Sturm N, Tissier F, Amar L, Bertherat J, Berthozat C, Chabre O, Do Cao C, Haissaguerre M, Pierre P, Briet C, Vezzosi D, Lifante JC, Pattou F, Mirallie E, Baudin E, Cariou B, Libe R, Drui D; for Comete-Cancer Network.

Mod Pathol. 2018 Nov;31(11):1708-1716. doi: 10.1038/s41379-018-0077-8. Epub 2018 Jun 19.

PMID:
29921900
8.

Activating PRKACB somatic mutation in cortisol-producing adenomas.

Espiard S, Knape MJ, Bathon K, Assié G, Rizk-Rabin M, Faillot S, Luscap-Rondof W, Abid D, Guignat L, Calebiro D, Herberg FW, Stratakis CA, Bertherat J.

JCI Insight. 2018 Apr 19;3(8). pii: 98296. doi: 10.1172/jci.insight.98296. [Epub ahead of print]

9.

MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.

Agosta C, Laugier J, Guyon L, Denis J, Bertherat J, Libé R, Boisson B, Sturm N, Feige JJ, Chabre O, Cherradi N.

Int J Cancer. 2018 Aug 15;143(4):944-957. doi: 10.1002/ijc.31363. Epub 2018 Mar 30.

PMID:
29516499
10.

MANAGEMENT OF ENDOCRINE DISEASE: Adrenocortical carcinoma: differentiating the good from the poor prognosis tumors.

Jouinot A, Bertherat J.

Eur J Endocrinol. 2018 May;178(5):R215-R230. doi: 10.1530/EJE-18-0027. Epub 2018 Feb 23. Review.

PMID:
29475877
11.

Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France.

Young J, Bertherat J, Vantyghem MC, Chabre O, Senoussi S, Chadarevian R, Castinetti F; Compassionalte use Programme.

Eur J Endocrinol. 2018 May;178(5):447-458. doi: 10.1530/EJE-17-0886. Epub 2018 Feb 22.

PMID:
29472378
12.

Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas.

Buffet A, Morin A, Castro-Vega LJ, Habarou F, Lussey-Lepoutre C, Letouzé E, Lefebvre H, Guilhem I, Haissaguerre M, Raingeard I, Padilla-Girola M, Tran T, Tchara L, Bertherat J, Amar L, Ottolenghi C, Burnichon N, Gimenez-Roqueplo AP, Favier J.

Cancer Res. 2018 Apr 15;78(8):1914-1922. doi: 10.1158/0008-5472.CAN-17-2463. Epub 2018 Feb 5.

PMID:
29431636
13.

SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.

Reznik Y, Barat P, Bertherat J, Bouvattier C, Castinetti F, Chabre O, Chanson P, Cortet C, Delemer B, Goichot B, Gruson D, Guignat L, Proust-Lemoine E, Sanson MR, Reynaud R, Boustani DS, Simon D, Tabarin A, Zenaty D.

Ann Endocrinol (Paris). 2018 Feb;79(1):1-22. doi: 10.1016/j.ando.2017.12.001. Epub 2018 Jan 12.

14.

Classic Kaposi Sarcoma: An Exceptional Cause of Adrenal Incidentaloma.

de Risi-Pugliese T, Genc S, Bertherat J, Larousserie F, Bollet M, Bassi C, Dupin N.

J Endocr Soc. 2017 May 5;1(6):737-741. doi: 10.1210/js.2017-00149. eCollection 2017 Jun 1.

15.

Polyendocrinopathy Resulting From Pembrolizumab in a Patient With a Malignant Melanoma.

Paepegaey AC, Lheure C, Ratour C, Lethielleux G, Clerc J, Bertherat J, Kramkimel N, Groussin L.

J Endocr Soc. 2017 Apr 28;1(6):646-649. doi: 10.1210/js.2017-00170. eCollection 2017 Jun 1.

16.

Pituitary Lesion of Unknown Origin: Think Epithelioid Angiosarcoma.

Bricaire L, Villa C, Brière M, Edjlali M, Larousserie F, d'Ussel M, Bertherat J, Boudou-Rouquette P, Groussin L.

J Endocr Soc. 2017 Jan 12;1(1):72-74. doi: 10.1210/js.2016-1010. eCollection 2017 Jan 1.

17.

Functional Implications of LH/hCG Receptors in Pregnancy-Induced Cushing Syndrome.

Plöckinger U, Chrusciel M, Doroszko M, Saeger W, Blankenstein O, Weizsäcker K, Kroiss M, Hauptmann K, Radke C, Pöllinger A, Tiling N, Steinmüller T, Huhtaniemi I, Quinkler M, Bertherat J, Lacroix A, Rahman N.

J Endocr Soc. 2017 Jan 12;1(1):57-71. doi: 10.1210/js.2016-1021. eCollection 2017 Jan 1.

18.

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B-Secreting Adrenocortical Carcinoma.

Espiard S, Lahlou N, Sibony M, Louiset E, Bienvenu M, Bertherat J, Dousset B, Groussin L, Libé R.

J Endocr Soc. 2017 Jan 12;1(1):46-50. doi: 10.1210/js.2016-1009. eCollection 2017 Jan 1.

19.

Genetics of tumors of the adrenal cortex.

Bonnet-Serrano F, Bertherat J.

Endocr Relat Cancer. 2018 Mar;25(3):R131-R152. doi: 10.1530/ERC-17-0361. Epub 2017 Dec 12. Review.

PMID:
29233839
20.

Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma.

Garinet S, Nectoux J, Neou M, Pasmant E, Jouinot A, Sibony M, Orhant L, Pipoli da Fonseca J, Perlemoine K, Bricaire L, Groussin L, Soubrane O, Dousset B, Libe R, Letourneur F, Bertherat J, Assié G.

Endocr Relat Cancer. 2018 Mar;25(3):L13-L17. doi: 10.1530/ERC-17-0467. Epub 2017 Dec 6. No abstract available.

PMID:
29212777

Supplemental Content

Loading ...
Support Center